Monocyte to large platelet ratio as a diagnostic marker for acute pulmonary embolism.
- 1Division of Critical Care, Department of Anesthesia and Critical Care, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- 2Department of Anesthesia and Critical Care, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Abstract
Background
Pulmonary embolism (PE) is a potentially life-threatening diagnosis that commonly presents to the emergency department with nonspecific symptoms. Despite advances in diagnostic algorithms, rapid identification remains challenging, particularly when definitive imaging is delayed or unavailable. Simple and readily available biomarkers may assist in the early evaluation of patients with suspected PE. This study investigated the diagnostic value of the monocyte-to-large platelet ratio (MLPR), a novel inflammation- and thrombosis-related biomarker, in acute PE.Methods
This retrospective exploratory study reviewed 115 medical records of patients presenting with suspected PE to the emergency department between January and December 2024 who underwent computed tomography pulmonary angiography. After applying exclusion criteria, 53 patients were included (25 PE, 28 non-PE). Admission complete blood count parameters, including MLPR, monocyte and lymphocyte counts, and derived ratios, were analyzed.Results
Age and sex distribution were similar between groups. Total leukocyte, monocyte, neutrophil, and lymphocyte counts were significantly higher in the PE group, alongside significantly elevated MLPR (1.19 ± 0.45 vs. 0.61 ± 0.39; P < 0.001), while NLR did not differ significantly (P = 0.4235). MLPR demonstrated the highest diagnostic performance among individual hematological markers (AUC 0.854, 95% CI 0.752-0.956; P < 0.001). Combining MLPR with lymphocyte count further improved diagnostic accuracy (AUC 0.907, 95% CI 0.827-0.986), achieving 92% sensitivity and 85.7% specificity.Conclusion
MLPR is a promising, readily available biomarker for diagnosing acute PE, with enhanced performance when combined with lymphocyte count.
Related
- Exploring the role of monocyte in pulmonary embolism via single‐cell transcriptome sequencing of peripheral blood
- Red Cell Distribution Width-to-Platelet Count Ratio as an Early Marker of Severity in Acute Pancreatitis: A Diagnostic Accuracy Study at a Tertiary Care Center
- Diagnostic challenge of pulmonary embolism during testosterone replacement therapy for primary hypogonadism
- Pituitary Apoplexy Complicated by Pulmonary Embolism in a Neurologically Complex Patient: A Diagnostic Challenge.
- Development of the OncoScore: A Diagnostic Prediction Score for Previously Unrecognized Malignancy in Patients with Acute Pulmonary Embolism
BibTeX
@article{awad2026monocyte,
title = {{Monocyte to large platelet ratio as a diagnostic marker for acute pulmonary embolism.}},
author = {Mohamed K A Awad and Reem H El Kabarity and Hadeel Magdy Abdelhamid and Azza M Youssef},
journal = {American heart journal plus : cardiology research and practice},
year = {2026},
month = oct,
doi = {10.1016/j.ahjo.2026.100951},
url = {https://europepmc.org/article/MED/42921207},
note = {CC BY},
}
RIS
TY - JOUR
TI - Monocyte to large platelet ratio as a diagnostic marker for acute pulmonary embolism.
AU - Mohamed K A Awad
AU - Reem H El Kabarity
AU - Hadeel Magdy Abdelhamid
AU - Azza M Youssef
PY - 2026
DA - 2026/10/13
JO - American heart journal plus : cardiology research and practice
DO - 10.1016/j.ahjo.2026.100951
UR - https://europepmc.org/article/MED/42921207
AB - Background Pulmonary embolism (PE) is a potentially life-threatening diagnosis that commonly presents to the emergency department with nonspecific symptoms. Despite advances in diagnostic algorithms, rapid identification remains challenging, particularly when definitive imaging is delayed or unavailable. Simple and readily available biomarkers may assist in the early evaluation of patients with suspected PE. This study investigated the diagnostic value of the monocyte-to-large platelet ratio (MLPR), a novel inflammation- and thrombosis-related biomarker, in acute PE.Methods This retrospective exploratory study reviewed 115 medical records of patients presenting with suspected PE to the emergency department between January and December 2024 who underwent computed tomography pulmonary angiography. After applying exclusion criteria, 53 patients were included (25 PE, 28 non-PE). Admission complete blood count parameters, including MLPR, monocyte and lymphocyte counts, and derived ratios, were analyzed.Results Age and sex distribution were similar between groups. Total leukocyte, monocyte, neutrophil, and lymphocyte counts were significantly higher in the PE group, alongside significantly elevated MLPR (1.19 ± 0.45 vs. 0.61 ± 0.39; P < 0.001), while NLR did not differ significantly (P = 0.4235). MLPR demonstrated the highest diagnostic performance among individual hematological markers (AUC 0.854, 95% CI 0.752-0.956; P < 0.001). Combining MLPR with lymphocyte count further improved diagnostic accuracy (AUC 0.907, 95% CI 0.827-0.986), achieving 92% sensitivity and 85.7% specificity.Conclusion MLPR is a promising, readily available biomarker for diagnosing acute PE, with enhanced performance when combined with lymphocyte count.
SN - 2666-6022
ER -